Greenfield, D. M. http://orcid.org/0000-0002-3733-2717
Salooja, N. http://orcid.org/0000-0001-5668-9001
Peczynski, C. http://orcid.org/0000-0002-3829-0088
van der Werf, S.
Schoemans, H. http://orcid.org/0000-0002-7568-8239
Hill, K. http://orcid.org/0000-0003-1347-7820
Cortelezzi, A.
Lupo-Stangellini, M. http://orcid.org/0000-0003-1382-6939
Özkurt, Z. N.
Arat, M.
Metzner, B.
Turlure, P.
Rovo, A. http://orcid.org/0000-0002-7757-4753
Socié, G.
Mohty, M. http://orcid.org/0000-0002-7264-808X
Nagler, A. http://orcid.org/0000-0002-0763-1265
Kröger, N. http://orcid.org/0000-0001-5103-9966
Dreger, P. http://orcid.org/0000-0002-7429-8570
Labopin, M. http://orcid.org/0000-0003-4514-4748
Han, T. S. http://orcid.org/0000-0003-2570-0938
Tichelli, A.
Duarte, R.
Basak, G.
Snowden, J. A. http://orcid.org/0000-0001-6819-3476
Article History
Received: 17 December 2020
Revised: 28 May 2021
Accepted: 7 July 2021
First Online: 17 July 2021
Competing interests
: JAS declares honoraria for speaking from Janssen and Gilead, an advisory board from Medac, and IDMC membership for a clinical trial supported by Kiadis.